A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate.

Source:http://linkedlifedata.com/resource/pubmed/id/12610745

Download in:

View as

General Info

PMID
12610745